Purpose: Preservation of renal function after nephron-sparing surgery (NSS) is multifactorial and the impact of individual factors on it is still a debate. This prospective study investigates the impact of factors responsible for quantitative and functional outcome after NSS. Patients and Methods: Fifty-two patients of localized renal mass (≤7 cm) were included in the study. A contrast-enhanced computed tomography abdomen was performed for characterization of tumor. Glomerular filtration rate (GFR) was calculated using Tc99m-diethylenetriamine pentaacetic acid (DTPA) scan and Cockcroft-Gault (CG) formula. All relevant intra-and peri-operative events were noted. Follow-up work up performed at 3 months. Results: Overall, the mean ischemia time was 30.6 min, with 7.7% decrease in renal volume in the operated moiety. In follow-up, the total and ipsilateral GFR decreased. Change in renal parenchymal volume, total GFR by CG and DTPA, split GFR of tumor-bearing moiety was significant in follow-up. Size, stage, polar location of tumor, duration of surgery, type of ischemia, preoperative chronic kidney disease, and need of blood transfusion did not affect change in renal volume and function in the follow-up period. Conclusion: Renal parenchymal loss and duration of ischemia have impact on the follow-up renal function.
Introduction
T he fundamental goal of nephron-sparing surgery (NSS) is to preserve renal function without compromising the oncologic outcomes. The ubiquitous use of, and improvement in, abdominal imaging modalities has resulted in increased detection of incidental renal masses that now account for 50%-65% of all diagnosed renal masses. These renal tumors are smaller, less likely to metastasize and hence often amenable to NSS. During the past 10-15 years, NSS has emerged as the gold standard for the treatment of small renal masses with equivalent oncological outcomes, better preservation of renal function, and improved overall survival compared with radical nephrectomy (RN). NSS has supplanted RN as the treatment of choice for T1 renal tumors when feasible, even in the absence of identifiable renal insufficiency. [1] [2] [3] [4] Total patients underwent partial nephrectomy (n = 54) well studied. The current literature also has suggested the functional outcome of the kidney is determined by the amount of preserved renal parenchyma and not on the size of the tumor. [2, 3] After NSS function of remaining renal mass can be assessed by serum creatinine, creatinine clearance (CrCl) by 24-h urine collection, contrast-enhanced computed tomography (CT) with CT GFR (estimation of GFR by enhancing renal volume), estimated GFR (e-GFR) by CG formula, GFR from using the abbreviated modification in diet and renal disease study equation, and Technetium Tc 99m-diethylenetriaminepentaacetic acid (Tc 99m-DTPA) renal scintigraphy. After NSS, remaining renal parenchyma may be measured by various means, for example, ultrasound, CT with volumetric measurement or magnetic resonance imaging. [4, [6] [7] [8] The present prospective study was aimed to evaluate the impact of various factors responsible for quantitative (as assessed by CT scan) and functional outcome (as assessed on DTPA scan/e-GFR) of NSS, at a short-term follow-up of 3 months.
Patients and Methods
i. Study design and patient characteristics: This was a prospective study, conducted from July 2012 to May 2014. All patients of the localized renal mass of size up to 7 cm were eligible. The study was approved by Institute's Ethics Committee, and all patients were explained in detail about the study protocol. An informed written consent was obtained from those willing to participate in the study. Patients not willing to participate, radiological evidence of locally advanced and metastatic disease, dialysis-dependent chronic kidney disease (CKD), allergy to intravenous contrast agents, or contraindications for contrast-enhanced computed tomography (CECT) were excluded from the study. Flowchart is given for the study design [ Figure 1 ] ii. Preoperative workup: A triphasic CECT of abdomen was performed for characterization of tumor. CT images in venous phases were analyzed using a real-time interaction approach on a dedicated syngo through (Siemens healthcare global) workstation with 3D rendering software [ Figure 2 ]. N-acetyl cysteine 600 mg twice a day was administered 2 days before CECT and continued for one day after the procedure in a patient with raised serum creatinine (S. Cr.) level (>1.2 mg/dl). Total and split GFR using Tc99 m DTPA scan was performed either before CECT scan or at least 2 weeks later iii. Estimation of renal function: GFR was calculated by (1 (2). 99Tc DTPA scan: Visual evaluation of the scintigraphy images was performed on the computer screen, then using Gates method (quantitative method) total and split GFR were estimated [ Figure 3 ]. A postoperative change in GFR of >5% over the baseline value was considered significant [9] iv. Perioperative outcome assessments: After complete workup and fitness for surgery, patients were taken for surgery under general anesthesia. In perioperative period, adequate hydration was maintained by measuring hourly urine output and nephrotoxic drugs were avoided. Standard protocol of laparoscopic/open NSS was followed.
Tumor resection was carried out in following steps (1) marking by monopolar diathermy, (2) resection of tumor with or without the help of intraoperative sonography, and (3) renorrhaphy in two layers with polyglactin 2-0 RB needle, calyceal repair separately if require with 3-0 polyglactin RB needle. 1 g/kg of 20% mannitol was administered by i.v., infusion 10-15 min before clamping renal vessels. Intraoperative hypothermia (whenever necessary) was achieved by surface cooling by ice slice for 10-15 min immediately after occlusion of the renal artery. Intraoperative parameters such as ischemia time, duration of surgery, blood loss, need of blood and blood product transfusion, urine output, and postoperative complications such as fever, bleeding, and urine leak were noted v. Follow-up: Patients were followed up at 1 and method, effect of ischemia on these parameters and local or distant recurrence by CECT scan at 3 months' follow-up, were measured in this study.
Statistical analysis
The data were analyzed using Statistical Package for the Social Sciences (SPSS Inc, Chicago, Illinois, USA) software version 17. Data were expressed in mean, median, and percentage. The normalcy of data was checked using One-Sample Kolmogorov-Smirnov Test. Statistical analysis was performed using
Fisher's exact test, one-way and two-way ANOVA, and multivariate linear regression model. Correlation was performed using Pearson coefficient of correlation. P = 0.05 or less was considered statistically significant.
Results
A total of 52 patients were assessed at baseline and 3 months following surgery. Baseline and follow-up, DTPA scan could be performed in 45 patients because of logistic reasons. Demographic, clinical, pathological, and operative data are summarized in Table 1 . Mean age at the time of presentation was 48.96 years and male preponderance was observed (71%). Majority of the tumors (75%) were incidentally detected. Fifteen (29%) patients had CrCl <60 ml/min/1.73 m 2 at presentation. In 33 (64%), exophytic component of tumor was >50%, tumor located at upper, lower, and interpolar site in 48%, 37%, and 15%, respectively. Mean duration of warm ischemia was 31.47 min (15-50) whereas mean cold ischemia duration was 33.38 min . Duration of warm ischemia was further categorized into two subgroups (>30 min in 14 patients and ≤30 min in 20 patients). Mean duration of surgery was 177 min (60-390) and it was more in laparoscopy cases. Mean blood loss was 311.2 ml (40-1800), in seven patients' blood loss was ≥500 ml, and eight patients needed blood transfusion. Grade 1 and 2 Clavien-Dindo complications was noted in 12 (23%) and 8 (15.38%) patients, respectively.
Quantitative and qualitative assessment of renal parenchyma in different group of ischemia is shown in Table 2 . Baseline mean renal parenchymal volume of tumor-bearing kidney was 190cc (standard error [SE] ± 5.81). Following NSS, at 3 months' follow-up, the renal volume reduced to 175.91cc (SE ± 4.73) which was statistically significant. The percentage split GFR of tumor-bearing kidney reduced significantly at follow-up from 51.36% (SE ± 2.11) to 31.8% (SE ± 1.32) whereas percent split GFR of opposite renal moiety showed a relative increase from 48.4% (SE ± 2.11) to 52.44% (SE ± 2.38). Change in renal parenchymal volume, total GFR by CG and DTPA, split GFR of tumor-bearing moiety was significant in all patients together and subgroups such as WIT, CIT, and zero ischemia time [ Table 2 ]. When subgroups of WIT compared, change in renal parenchymal volume, total GFR by CG formula, split GFR of tumor-bearing, and opposite moiety was not different; however, total GFR by DTPA scan was significantly low in ≤30 WIT group [ Table 3 ].
Preoperative CrCl <60 ml/min versus >60 ml/min, approach to surgery open versus laparoscopic and stage of tumor T1 versus T2 did not show any statistically significant differential effect in their change in renal parenchymal volume, total and percentage split GFR of tumor-bearing kidney. On multivariate analysis 1. Age and hospital stay were independent variables for change in total GFR by DTPA scan (r = 0.609, P = 0.0001) 2. Approach (open/lap) of surgery was independent variable for decrease in split renal function of tumor-bearing kidney was associated with (r = 0.302, P = 0.04). Positive surgical margins were observed in two patients operated laparoscopically; both in follow-up imaging did not show any radiological evidence of tumor or recurrence till now.
Discussion
Different authors have described multiple factors affecting renal function after NSS such as age, gender, tumor size, ischemia type and time, remaining renal volume, and postoperative complication. The individual contribution of each factor for final renal volume and function is still not very clear. [2, 8, 10, 11] The upper limit of the ischemic time that affect renal function remains controversial to date. Based on the previous literature reports till 1980, 30 min is the generally accepted upper limit. Thompson et al. , studied the effect of renal vessels clamping during partial nephrectomy in patients with a solitary kidney. They found that warm ischemic time >20 min and cold ischemic time >35 min was associated with a higher increase in serum creatinine levels. However many authors reported that renal parenchyma was independent of WIT and many factors play role. [12] [13] [14] [15] Also review of the literature by Volpe et al., showed that even WIT >30 min have no adverse effects in patients with bilateral functioning kidneys, [16] in this study, WIT was >30 min in 14 patients. Nevertheless, ischemia should be kept as short as possible especially for patients with T1 or large tumor and patient with at risk of progression of renal functions.
Most surgeons prefer the use of vascular clamping to minimize blood loss, acquire good visibility of the tumor bed, allow safe assessment of oncologic margins, and enable quick hemostasis. [12, 13, 17] This warm ischemia duration is proven to be an important modifiable factor, but still definitive upper limit is yet to be defined. It is well known that WIT leads to hypoxic-reperfusion injury to ipsilateral renal moiety which is directly related to the duration of ischemia, but the natural history of this damage is not well understood. Although every minute counts after the renal hilum is clamped, data suggest that safe WIT ranges between 20 and 25 min, but a limit of 30 min is considered safe time for WIT. Cold ischemia is well tolerated by kidney up to 120 min depending on technique used for cooling. Nevertheless, cold ischemia with ice slush should be kept as short as possible. [2, 5, 18, 19] In our study, CIT was in acceptable limit, whereas duration of warm ischemia exceeded 30 min in 14 patients.
There was significant decrease in renal parenchymal volume, percentage split GFR, and total GFR by DTPA scan in both warm and cold ischemia group whereas GFR by CG formula was not changed. On subgroup comparison between WIT >30 min and <30 min, there was difference in percentage split renal function and loss of renal parenchyma only as shown in Table 2 .
In nonclamp group, only renal parenchymal loss was significant and rest of the parameters did not show any significant change. The magnitude of the decrease in GFR appears to be influenced by three factors -(1) functional volume loss, (2) ischemia-related acute kidney injury, and (3) mechanical trauma effects. In review of literature, Volpe mentioned that complex and large tumor need longer ischemia and probably large nondiseased parenchyma loss and eventually more loss of renal function. Furthermore, surgical technique plays an important role in the form of renorrhaphy; intraoperative ultrasound helps in identifying true margins and also avoid fear of cutting into tumor. [19, 16] In this study, the surgical steps were almost same for all surgeons, but renorrhaphy was probably bit different for the case to case. We also have dedicated intraoperative ultrasound probe to guide surgical steps whenever necessary.
Serum creatinine level is an effective parameter for monitoring renal functional changes in patients with a solitary kidney; it is not an effective parameter for cases with a normal opposite kidney. In the study by Joniau et al., T1a and T1b were compared and found that patient characteristics were different; however, the overall complication rate, pathological, and oncological variables were not significantly different. Many investigators have suggested that it is the inherent tumor biology rather than surgical approach or tumor size that has the major influence on outcomes after NSS for T1 RCC. [15, 20] In this study also, there was no homogenous change in GFR by DTPA and CG formula, which is based on serum creatinine.
It is assumed that function of the normal side did not change. However, functional adaptation occurs in the contralateral side, and to precisely evaluate any damage caused by NSS, the quantitative split renal function should be investigated. [13] Data have shown that the percentage decrease in functional kidney volume correlates strongly with the percentage decrease in GFR at late points after NSS. These data also demonstrate that volume loss impacts GFR to a greater degree than ischemic injury when ischemia time is maintained within acceptable time limits. [21, 22] The most important variables associated with short-and long-term renal function after NSS are the quality and the quantity of kidney remaining after the procedure. In our study, also there is a significant renal volume loss, but it is not reflected by a similar decrease in GFR both by DTPA and CG formula which could possibly be due to transient increase in percentage renal function of opposite moiety. Although the quantity preserved has traditionally been considered a nonmodifiable factor, there are some authors who have highlighted the potential importance of the precision of excision and reconstruction in an effort to optimize this parameter. [20] Renal scintigraphy is the only method that allows clinicians to quantify real changes in split renal-functional loss of the tumor-bearing kidney after NSS. [8, 18] In our study, we used DTPA renal scan to evaluate split GFR; it could be done in 45 patients and Gates method was used instead of Plasma method. Lane et al., studied 1169 patients retrospectively and found that increasing age, male gender, and larger tumor size were significant predictors of fall in postoperative GFR. Maurice et al., studied various factors affecting postsurgery renal volume loss and found that male sex, larger tumors, endophytic tumors, open approach, increased bleeding, and higher surgeon volume were independently associated with more volume loss [2, 3, 23] However, in our study, age, gender, duration of ischemia, exophytic component of tumor, and approach for surgery were independent variable for renal parenchymal volume, total and split GFR, whereas size, stage, polar location of tumor, duration of surgery, preoperative CKD, and need of blood transfusion did not affect change in renal volume and function in the follow-up period. According to literature patients with preoperatively compromised renal function are prone for decreased renal function and also the duration of ischemia should strictly keep as short as possible. In this study, 29% patient's GFR was <60 ml/min, preoperatively, however, there was no deterioration of renal function in postoperatively; probably, we did not include advanced CKD patients. Approach to surgery has mixed results in term of postoperative outcome; one study showed better postoperative renal function after laparoscopic approach while other showed no difference, in this study, there was no effect of the approach of surgery. [16, 24, 25] 
Conclusion
In this prospective study, we studied that quality and quantity of renal tissue that is preserved after surgery have effect on short-term renal function. Functional renal parenchymal volume correlates to split GFR of ipsilateral moiety, and functional parenchyma further depends on duration of ischemia not the type of ischemia. Duration of ischemia is modifiable factor; it should be kept short for both warm as well as cold. Further studies are needed with measurement of tumor complexity to study true loss of ipsilateral renal function.
Following are shortcoming of the present study.
• Small sample size • Surgery was not performed by a single surgeon • Surgical technique could have been more elaborative for different complexity of tumor • Intraoperative cut specimen could have been seen to look loss of normal renal parenchyma • Renal nephrometry score is standard tool to calculate complexity of tumor; we did not consider all parameter of nephrometry score • GFR by DTPA scan could not be performed in all patients • GFR by DTPA camera method is not as accurate as DTPA by Plasma method.
